SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021689
Filing Date
2020-02-14
Accepted
2020-02-14 16:05:49
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVEF MANAGEMENT IV, LLCVENROCK ENTREPRENEURS FUND IV, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VENROCK MANAGEMENT IV, LLCVENROCK PARTNERS MANAGEMENT, LLCVENROCK PARTNERS, L.P.VHCP CO-

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207550d1_sc13ga.htm SC 13G/A 346404
  Complete submission text file 0001104659-20-021689.txt   348503
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650-475-3734
VENROCK ASSOCIATES IV L P (Filed by) CIK: 0001277997 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88741 | Film No.: 20619456
SIC: 2834 Pharmaceutical Preparations